$FB Company News Google now offers employees ferry

New Post Public Reply Private Reply Replies (0) Message Board

Jan 9, 2014 at 10:58 PM

$FB Company News

Google now offers employees ferry service from San Francisco 7:02 p.m. Today - blogs.marketwatch.com
Angie’s List a rare gainer among weak tech stocks 5:02 p.m. Today - Rex Crum
Canada trying to lure Google, Facebook operations to keep data away from NSA spying: report 2:25 p.m. Today - blogs.marketwatch.com
A Revolution Investing approach to China: Short NQ Mobile and Buy Baidu 1:58 p.m. Today - blogs.marketwatch.com
Glamour stocks hit sweet spot 1:44 p.m. Today - The Trading Deck
Newscast: Planned job cuts fall 32% 8:40 a.m. Today - MarketWatch
What to expect from Twitter CEO Costolo's keynote at the CES 12:14 p.m. Jan. 8, 2014 - blogs.marketwatch.com
With Mulally out, Microsoft narrows CEO search 10:49 a.m. Jan. 8, 2014 - Rex Crum
Micron leads chip-stock rise; Twitter, Microsoft slump 10:11 a.m. Jan. 8, 2014 - Steve Goldstein
Gold to $960, Ford keeps its man and we stink at trading stocks 8:54 a.m. Jan. 8, 2014 - blogs.marketwatch.com
S&P, Nasdaq rally from technical support 12:00 p.m. Jan. 7, 2014 - Michael Ashbaugh
S&P, Nasdaq rally from technical support 11:48 a.m. Jan. 7, 2014 - Michael Ashbaugh
Tech stocks mostly rise in early trading 9:48 a.m. Jan. 7, 2014 - Rex Crum
Pandora gains; Twitter, Microsoft pace tech losses 4:58 p.m. Jan. 6, 2014 - Rex Crum
Twitter seen as riskier compared to Facebook 4:44 p.m. Jan. 6, 2014 - Rex Crum
Stock market live blog: S&P 500 falls for 3rd day; Facebook rises, Twitter falls; odds on 'rational exuberance' (Recap) 4:03 p.m. Jan. 6, 2014 - blogs.marketwatch.com
Sirius soars; Twitter tumbles on downgrade 3:49 p.m. Jan. 6, 2014 - Ben Eisen
Why hackers want your phone number 8:16 a.m. Jan. 4, 2014 - Quentin Fottrell
Winklevoss twins invest in new hedge fund: report 5:01 p.m. Jan. 3, 2014 - Sital S. Patel
Apple slides late in mixed day for tech stocks 4:51 p.m. Jan. 3, 2014 - Rex Crum

Another Chaotic Day 4:37 p.m. Today - RealMoney.com
The Prisoner's Dilemma Demands Selling Twitter 3:28 p.m. Today - Seeking Alpha
Google to Introduce Android to Cars - Analyst Blog 3:26 p.m. Today - Zacks.com
Analyst Makes the Case Facebook Will Steal Share from TV Ad Market 2:38 p.m. Today - benzinga.com
Rules of the Game: In International Waters 2:00 p.m. Today - RealMoney.com
Twitter lower; Cowen survey suggests ad ROI below Facebook, LinkedIn 1:50 p.m. Today - Seeking Alpha
Facebook Shares Up; Buys Start-Up - Analyst Blog 12:50 p.m. Today - Zacks.com
Why Twitter (TWTR) Is Falling Today 12:35 p.m. Today - TheStreet.com
Sunny Forecast Pushes Facebook to Record 12:24 p.m. Today - Wall St. Cheat Sheet
Facebook (FB) Still a Hold, Say TheStreet 11:45 a.m. Today - TheStreet.com
Three Reasons Why Microsoft Should Buy LinkedIn 11:31 a.m. Today - TheStreet.com
Facebook Or Google? Maybe Choose Both 11:19 a.m. Today - Seeking Alpha
Twitter Ad ROI Worse Than Facebook, LinkedIn: Analyst 10:51 a.m. Today - Investors Business Daily
New Lifetime High Today: Facebook Inc Class A (FB) 9:45 a.m. Today - TheStreet.com
Tech Premarket: Sirius, Apple, Riverbed, IBM 9:26 a.m. Today - TheStreet.com
Merrill Lynch Top Internet Stocks to Buy for 2014 9:13 a.m. Today - 247WallSt.com
TWTR – Twitter Might be the Canary in the Coal Mine 8:00 a.m. Today - InvestorPlace.com
AT&T Gets Creative With ‘Sponsored Data’ Mobile Ads 7:45 a.m. Today - InvestorPlace.com
Stay Away from Angie’s List – ANGI Stock Upgrade Is Overly Optimistic 5:39 a.m. Today - InvestorPlace.com
FB Stock – Facebook Shares Hit Record High 4:54 a.m. Today - InvestorPlace.com

Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 9:31 a.m. Today - PR Newswire
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
U.S. Stocks Aim to Push Technology Sector to New Levels: NXT-ID, Inc, Pandora, Facebook, Plug Power, Yahoo! 8:30 a.m. Jan. 8, 2014 - PR Newswire
Morning Buzzers: Facebook Inc, Galena Biopharma Inc, Plug Power Inc, Cell Therapeutics Inc, Advanced Micro Devices 10:50 a.m. Jan. 7, 2014 - ACCESSWIRE
Facebook to Announce Fourth Quarter and Full Year 2013 Results 9:00 a.m. Jan. 6, 2014 - PR Newswire
Service Up-gradation, Stock Price Update, and Appointments - Research Report on Facebook, Yahoo, LinkedIn, Groupon, and IAC 8:00 a.m. Jan. 6, 2014 - PR Newswire
Investors Recap: Bank of America Corp, Organovo Holdings, Facebook Inc, Baidu Inc 11:40 a.m. Jan. 3, 2014 - ACCESSWIRE
Morning Buzzers: Facebook Inc, Apple Inc, Tesla Motors Inc, Tiger Oil and Energy 10:04 a.m. Dec. 30, 2013 - ACCESSWIRE
Morning Market Inspection: Facebook, Twitter, LinkedIn, and IAC/InterActiveCorp 8:00 a.m. Dec. 30, 2013 - PR Newswire
Early Buzzers: Facebook Inc, WPCS International Incorporated, Endeavor IP, Bison Petroleum 10:45 a.m. Dec. 27, 2013 - ACCESSWIRE
Breakout Stocks: Facebook Inc, Tiger Oil and Energy Inc, YRC Worldwide, Intel Corporation 10:31 a.m. Dec. 23, 2013 - ACCESSWIRE
Facebook Announces Pricing of Follow-On Offering 4:59 p.m. Dec. 20, 2013 - PR Newswire
Finkelstein Thompson LLP and Lovell Stewart Halebian Jacobson LLP Defeat NASDAQ's Motion to Dismiss Shareholders' Negligence Claims in Connection with Facebook IPO 1:09 p.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Product Enhancements, Dividends, and Contract Updates - Research Report on Facebook, EMC, Crown Castle, Qihoo, and Broadcom 8:00 a.m. Dec. 19, 2013 - PR Newswire
Facebook Announces Proposed Follow-On Offering 6:17 a.m. Dec. 19, 2013 - PR Newswire
Opening Buzzers: Tesla Motors Inc, Facebook Inc, Intel Corporation, Cisco Systems 10:31 a.m. Dec. 18, 2013 - ACCESSWIRE
U.S. Stocks See Significant Gains as the Year End Nears - Company Announces Dividend to its Shareholders 9:05 a.m. Dec. 17, 2013 - PR Newswire
Morning Buzz: Facebook Inc, Apple Inc, Himax Technologies, Tesla Motors Inc 11:12 a.m. Dec. 16, 2013 - ACCESSWIRE
Insider Trading Growth of Facebook, Yahoo, Opko Health 8:55 a.m. Dec. 16, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Fibocom LTE Modules Test Drive Satellite Connectivity

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

LG's ASIL D Certification: A Game Changer in Autos

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...